Demant gets EU approval for divestiture to Cochlear
The European Commission has approved Danish Demant’s partial divestment of its surgical division, Oticon Medical, to Australian Cochlear.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.